Bright Minds Biosciences Inc. (DRUG) total debt

Total debt · fiscal 2025
CA$125.78K

Bright Minds Biosciences Inc. (DRUG) carried total debt of CA$125.78K at the end of fiscal 2025 (September 30, 2025). That is 5.7% higher than the CA$118.96K of fiscal 2024. Figures as of 18 Nov 2026, 04:42 UTC, from Yahoo Finance.

Key facts

Total debt, fiscal 2025
CA$125.78K
Change on fiscal 2024
+5.7%
Highest on record
CA$139.91Kfiscal 2022
Lowest on record
CA$73.55Kfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in CAD. Figures, not advice.

Bright Minds Biosciences Inc. total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was CA$139.91K in fiscal 2022 and the lowest CA$73.55K in fiscal 2023.

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Bright Minds Biosciences Inc. total debt, year by year

Bright Minds Biosciences Inc. (DRUG) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025CA$125.78K 5.7% up0.0×
2024CA$118.96K 61.7% up0.0×
2023CA$73.55K 47.4% down0.0×
2022CA$139.91K—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on DRUG

Bright Minds Biosciences Inc., figure by figure

Bright Minds Biosciences Inc. (DRUG) overview: price, valuation and scorecard

Bright Minds Biosciences Inc. total debt: questions and answers

How much debt does Bright Minds Biosciences Inc. have?

Bright Minds Biosciences Inc. (DRUG) carried total debt of CA$125.78K at the end of fiscal 2025 (September 30, 2025). That is 5.7% higher than the CA$118.96K of fiscal 2024.

What are the highest and lowest total debt figures on record for Bright Minds Biosciences Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was CA$139.91K in fiscal 2022 and the lowest CA$73.55K in fiscal 2023.

How does Bright Minds Biosciences Inc.'s debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

How is Bright Minds Biosciences Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bright Minds Biosciences Inc. (DRUG) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/DRUG/total-debt

Underlying data: Yahoo Finance.